Alizé Pharma

Scroll
Investment area
Novo Ventures
Region
Europe
Website
https://www.alz-pharma.com/

Alizé Pharma 3 develops innovative therapeutic peptides for rare endocrine and metabolic diseases. Their ambition is to become a leading rare disease company with U.S. and European operations to support
global development of our products.